Class II-Associated Invariant Chain Peptide Expression on Myeloid Leukemic Blasts Predicts Poor Clinical Outcome
Martine E.D. Chamuleau(Hovon), Gert J. Ossenkoppele(Dutch Cancer Society), Arjan A. van de Loosdrecht(Dutch Cancer Society), S. Marieke van Ham(Sanquin), Theresia M. Westers(Vrije Universiteit Amsterdam), Chris J.L.M. Meijer(Dutch Cancer Society), Adri Zevenbergen(Amsterdam UMC Location VUmc), Yuri Souwer(The Netherlands Cancer Institute), Johannes Berkhof(Amsterdam University Medical Centers)
Cited by 63
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k